Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'OLANZAPINE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 530 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Vittorio Mapelli
      Costo ed efficacia del trattamento della schizofrenia con olanzapina e risperidone: evidenze per il SSN

      Farmeconomia e percorsi terapeutici
    2. Giorgio D'Allio; fernando Rutto; Michela Coppi; Luca Guidi
      Livello di dipendenza dai Servizi Territoriali e costi relativi al trattamento della schizofrenia

      Farmeconomia e percorsi terapeutici
    3. Egidio Filippelli; Giovanni Biricolti; Cinzia Scarano; Federico Russo; Lucio Luciano
      Il trattamento dei disturbi psicotici con olanzapina, risperidone e neurolettici tipici: una valutazione comparativa di costo/efficacia in una realtÓ psichiatrica locale

      Farmeconomia e percorsi terapeutici
    4. Angelomarco Barioglio; Luca Guidi; Giorgio Mariani
      Influenza del trattamento della schizofrenia con neurolettici tipici o olanzapina sui costi sanitari e sugli outcomes lavorativi

      Farmeconomia e percorsi terapeutici
    5. Berlind, A
      Monoamine pharmacology of the lobster cardiac ganglion

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY
    6. Smith, RC; Infante, M; Singh, A; Khandat, A
      The effects of olanzapine on neurocognitive functioning in medication-refractory schizophrenia

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    7. Ghaemi, SN
      On defining 'mood stabilizer'

      BIPOLAR DISORDERS
    8. Boulton, DW; Markowitz, JS; DeVane, CL
      A high-performance liquid chromatography assay with ultraviolet detection for olanzapine in human plasma and urine

      JOURNAL OF CHROMATOGRAPHY B
    9. Weigmann, H; Hartter, S; Maehrlein, S; Kiefer, W; Kramer, G; Dannhardt, G; Hiemke, C
      Simultaneous determination of olanzapine, clozapine and demethylated metabolites in serum by on-line column-switching high-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY B
    10. Bao, JQ; Potts, BD
      Quantitative determination of olanzapine in rat brain tissue by high-performance liquid chromatography with electrochemical detection

      JOURNAL OF CHROMATOGRAPHY B
    11. Raggi, MA; Casamenti, G; Mandrioli, R; Volterra, V
      A sensitive high-performance liquid chromatographic method using electrochemical detection for the analysis of olanzapine and desmethylolanzapine in plasma of schizophrenic patients using a new solid-phase extraction procedure

      JOURNAL OF CHROMATOGRAPHY B
    12. Peuskens, J; De Hert, M; Jones, M
      The clinical value of risperidone and olanzapine: A meta-analysis of efficacy and safety

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    13. Segal, J; Isaacs, MD; Berk, M
      Neuroleptic malignant syndrome: Possible induction by olanzapine in a casewith relapsing catatonia

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    14. Jarema, M; Konieczynska, Z
      Quality of life in schizophrenia: Impact of psychopathology, patients' gender and antipsychotic treatment

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    15. Khouzam, HR; Gazula, K
      Clinical experience with olanzapine in the course of post-operative delirium associated with psychosis in geriatric patients: A report of three cases

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    16. Al-Adwani, A; Nabi, W
      Coexisting Diogenes and Capgras syndromes

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    17. Gimenez-Roldan, S; Mateo, D; Navarro, E; Gines, MM
      Efficacy and safety of clozapine and olanzapine: an open-label study comparing two groups of Parkinson's disease patients with dopaminergic-induced psychosis

      PARKINSONISM & RELATED DISORDERS
    18. Wolters, EC; Berendse, HW
      Management of psychosis in Parkinson's disease

      CURRENT OPINION IN NEUROLOGY
    19. Gobbi, G; Pulvirenti, L
      Long-term treatment with dozapine in an adult with autistic disorder accompanied by aggressive behaviour

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    20. Tempier, R; Pawliuk, N
      Influence of novel and conventional antipsychotic medication on subjectivequality of life

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    21. Purdon, SE; Malla, A; Labelle, A; Lit, W
      Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    22. Khullar, A; Chue, P; Tibbo, P
      Quetiapine and obsessive-compulsive symptoms (OCS): case report and reviewof atypical antipsychotic-induced OCS

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    23. Tauscher, J; Kapur, S
      Choosing the right dose of antipsychotics in schizophrenia - Lessons from neuroimaging studies

      CNS DRUGS
    24. Edell, WS; Tunis, SL
      Antipsychotic treatment of behavioral and psychological symptoms of dementia in geropsychiatric inpatients

      AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
    25. Rosebraugh, CJ; Flockhart, DA; Yasuda, SU; Woosley, RL
      Olanzapine-induced rhabdomyolysis

      ANNALS OF PHARMACOTHERAPY
    26. Bonanno, DG; Davydov, L; Botts, SR
      Olanzapine-induced diabetes mellitus

      ANNALS OF PHARMACOTHERAPY
    27. Roefaro, J; Mukherjee, SM
      Olanzapine-induced hyperglycemic nonketonic coma

      ANNALS OF PHARMACOTHERAPY
    28. Bryden, KE; Carrey, NJ; Kutcher, SP
      Update and recommendations for the use of antipsychotics in early-onset psychoses

      JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    29. Mehler, C; Wewetzer, C; Schulze, U; Warnke, A; Theisen, F; Dittmann, RW
      Olanzapine in children and adolescents with chronic anorexia nervosa. A study of five cases

      EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
    30. Shiigi, Y; Casey, DE
      Effects of benztropine on ketamine-induced behaviors in Cebus monkeys

      BEHAVIOURAL PHARMACOLOGY
    31. Krebs, S; Dormann, H; Muth-Selbach, U; Hahn, EG; Brune, K; Schneider, HT
      Risperidone-induced cholestatic hepatitis

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    32. Fenton, WS
      Comorbid conditions in schizophrenia

      CURRENT OPINION IN PSYCHIATRY
    33. Barnes, TRE; Joyce, EM
      Antipsychotic drug treatment: recent advances

      CURRENT OPINION IN PSYCHIATRY
    34. Markianos, M; Hatzimanolis, J; Lykouras, L
      Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    35. Bernardo, M; Parellada, E; Lomena, F; Catafau, AM; Font, M; Gomez, JC; Lopez-Carrero, C; Gutierrez, F; Pavia, J; Salamero, M
      Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint [I-123]IBZM SPECT study

      PSYCHIATRY RESEARCH-NEUROIMAGING
    36. Melkersson, K; Khan, A; Hilding, A; Hulting, AL
      Different effects of antipsychotic drugs on insulin release in vitro

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    37. Lykouras, L; Gournellis, R; Angelopoulos, E
      Manic symptoms induced by olanzapine

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    38. Gefvert, O; Lundberg, T; Wieselgren, IM; Bergstrom, M; Langstrom, B; Wiesel, FA; Lindstrom, L
      D-2 and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    39. Schreinzer, D; Frey, R; Stimpfl, T; Vycudilik, W; Berzlanovich, A; Kasper, S
      Different fatal toxicity of neuroleptics identified by autopsy

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    40. Floris, M; Lejeune, J; Deberdt, W
      Effect of amantadine on weight gain during olanzapine treatment

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    41. Liebzeit, KA; Markowitz, JS; Caley, CF
      New onset diabetes and atypical antipsychotics

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    42. Kasper, S; Tauscher, J; Heiden, A
      Quetiapine: efficacy and tolerability in schizophrenia

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    43. McGlashan, TH
      Psychosis treatment prior to psychosis onset: ethical issues

      SCHIZOPHRENIA RESEARCH
    44. Naber, D; Moritz, S; Lambert, M; Rajonk, F; Holzbach, R; Mass, R; Andresen, B; Frank, P; Rudiger, H; Reinhard, M; Burghard, A
      Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs

      SCHIZOPHRENIA RESEARCH
    45. Rabinowitz, J; Davidson, M
      Risperidone versus haloperidol in long-term hospitalized chronic patients in a double blind randomized trial: a post hoc analysis

      SCHIZOPHRENIA RESEARCH
    46. Ganguli, R; Brar, JS; Ayrton, Z
      Weight gain over 4 months in schizophrenia patients: a comparison of olanzapine and risperidone

      SCHIZOPHRENIA RESEARCH
    47. Rasmussen, T; Fink-Jensen, A; Sauerberg, P; Swedberg, MDB; Thomsen, C; Sheardown, MJ; Jeppesen, L; Calligaro, DO; DeLapp, NW; Whitesitt, C; Ward, JS; Shannon, HE; Bymaster, FP
      The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance

      SCHIZOPHRENIA RESEARCH
    48. Cuesta, MJ; Peralta, V; Zarzuela, A
      Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study

      SCHIZOPHRENIA RESEARCH
    49. Siris, SG; Addington, D; Azorin, JM; Falloon, IRH; Gerlach, J; Hirsch, SR
      Depression in schizophrenia: Recognition and management in the USA

      SCHIZOPHRENIA RESEARCH
    50. Sacristan, A; Gomez, JC; Badia, X; Kind, P
      Global index of safety (GIS): A new instrument to assess drug safety

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    51. Scheepers, FE; Wied, CCG; Westenberg, HGM; Kahn, RS
      The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients

      NEUROPSYCHOPHARMACOLOGY
    52. Moy, SS; Knapp, DJ; Breese, GR
      Effect of olanzapine on functional responses from sensitized D-1-dopamine receptors in rats with neonatal dopamine loss

      NEUROPSYCHOPHARMACOLOGY
    53. Sakai, K; Gao, XM; Hashimoto, T; Tamminga, CA
      Traditional and new antipsychotic drugs differentially alter neurotransmission markers in basal ganglia-thalamocortical neural pathways

      SYNAPSE
    54. Verma, S; Orengo, CA; Kunik, ME; Hale, D; Molinari, VA
      Tolerability and effectiveness of atypical antipsychotics in male geriatric inpatients

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    55. Arnaout, MS; Antun, FP; Ashkar, K
      Neuroleptic malignant syndrome with olanzapine associated with severe hypernatremia

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    56. Reading, PJ; Luce, AK; McKeith, IG
      Rivastigmine in the treatment of parkinsonian psychosis anti cognitive impairment: Preliminary findings from an open trial

      MOVEMENT DISORDERS
    57. Factor, SA; Friedman, JH; Lannon, MC; Oakes, D; Bourgeois, K
      Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: Results of the 12 week open label extension in the PSYCLOPS trial

      MOVEMENT DISORDERS
    58. Jacobs, ES; Dickstein, DP; Liebelt, EL
      Novel psychotropic medications in children: New toxicities to master

      PEDIATRIC EMERGENCY CARE
    59. Burns, MJ
      The pharmacology and toxicology of atypical antipsychotic agents

      JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY
    60. Rao, ML; Hiemke, C; Grasmader, K; Baumann, P
      Olanzapine: Pharmacology, pharmacokinetics and therapeutic drug monitoring

      FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
    61. Francobandiera, G
      Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: An open study

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    62. McIntyre, RS; McCann, SM; Kennedy, SH
      Antipsychotic metabolic effects: Weight gain, diabetes mellitus, and lipidabnormalities

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    63. Benazzi, F
      Quetiapine-associated hypomania in a woman with schizoaffective disorder

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    64. Sa, DS; Kapur, S; Lang, AE
      Amoxapine shows an antipsychotic effect but worsens motor function in patients with Parkinson's disease and psychosis

      CLINICAL NEUROPHARMACOLOGY
    65. Esel, E; Basturk, M; Gonul, AS; Kula, M; Turan, MT; Yabanoglu, I; Sofuoglu, S
      Effects of olanzapine and haloperidol on serum prolactin levels in male schizophrenic patients

      PSYCHONEUROENDOCRINOLOGY
    66. Derissen, W
      Atypical neuroleptic drugs

      AKTUELLE NEUROLOGIE
    67. Konig, F; von Hippel, C; Petersdorff, T; Neuhoffer-Weiss, M; Wolfersdorf, M; Kaschka, WP
      First experiences in combination therapy using olanzapine with SSRIs (Citalopram, paroxetine) in delusional depression

      NEUROPSYCHOBIOLOGY
    68. Lykouras, L; Markianos, M; Hatzimanolis, J; Oulis, P
      Dopamine receptor responsivity in schizophrenic patients in a drug-free state and after treatment with olanzapine

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    69. Hatch, CD; Lund, BC; Perry, PJ
      Failed challenge with quetiapine after neuroleptic malignant syndrome withconventional antipsychotics

      PHARMACOTHERAPY
    70. Carnahan, RM; Lund, BC; Perry, PJ
      Ziprasidone, a new atypical antipsychotic drug

      PHARMACOTHERAPY
    71. Jann, MW; Chang, WH; Lane, HY
      Differences in haloperidol epidemiologic pharmacokinetic studies

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    72. Cordeiro, Q; Elkis, H
      Pancreatitis and cholestatic hepatitis induced by risperidone

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    73. Meehan, K; Zhang, F; David, S; Tohen, M; Janicak, P; Small, J; Koch, K; Rizk, R; Walker, D; Tran, P; Breier, A
      A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutelyagitated patients diagnosed with bipolar mania

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    74. Bouchard, RH; Demers, MF; Simoneau, I; Almeras, N; Villeneuve, J; Mottard, JP; Cadrin, C; Lemieux, I; Despres, JP
      Atypical antipsychotics and cardiovascular risk in schizophrenic patients

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    75. Petty, F; Brannan, S; Casada, J; Davis, LL; Gajewski, V; Kramer, GL; Stone, RC; Teten, AL; Worchel, J; Young, KA
      Olanzapine treatment for post-traumatic stress disorder: an open-label study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    76. Kasper, S; Rosillon, D; Duchesne, I
      Risperidone Olanzapine Drug Outcomes studies in Schizophrenia (RODOS): efficacy and tolerability results of an international naturalistic study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    77. Kasper, S; Jones, M; Duchesne, I
      Risperidone Olanzapine Drug Outcomes studies in Schizophrenia (RODOS): health economic results of an international naturalistic study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    78. Butterfield, MI; Becker, ME; Connor, KM; Sutherland, S; Churchill, LE; Davidson, JRT
      Olanzapine in the treatment of post-traumatic stress disorder: a pilot study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    79. Mir, S; Taylor, D
      Atypical antipsychotics and hyperglycaemia

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    80. Licht, RW; Bysted, M; Christensen, H
      Fixed-dosed risperidone in mania: an open experimental trial

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    81. Kodesh, A; Finkel, B; Lerner, AG; Kretzmer, G; Sigal, M
      Dose-dependent olanzapine-associated leukopenia: three case reports

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    82. Buchman, N; Strous, RD; Ulman, AM; Lerner, M; Kotler, M
      Olanzapine-induced leukopenia with human leukocyte antigen profiling

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    83. Kane, J
      Progress defined - short-term efficacy, long-term effectiveness

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    84. Casey, DE
      Barriers to progress - the impact of tolerability problems

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    85. Merrick, TC; Felo, JA; Jenkins, AJ
      Tissue distribution of olanzapine in a postmortem case

      AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY
    86. Gonzalez-Pinto, A; Lalaguna, B; Mosquera, F; de Heredia, JLP; Gutierrez, M; Ezcurra, J; Gilaberte, I; Tohen, M
      Use of olanzapine in dysphoric mania

      JOURNAL OF AFFECTIVE DISORDERS
    87. Weigmann, H; Gerek, S; Zeisig, A; Muller, M; Hartter, S; Hiemke, C
      Fluvoxamine but not sertraline inhibits the metabolism of olanzapine: Evidence from a therapeutic drug monitoring service

      THERAPEUTIC DRUG MONITORING
    88. Olesen, OV; Poulsen, B; Linnet, K
      Fully automated on-line determination of olanzapine in serum for routine therapeutic drug monitoring

      THERAPEUTIC DRUG MONITORING
    89. Bickeboeller-Friedrich, J; Maurer, HH
      Screening for detection of new antidepressants, neuroleptics, hypnotics, and their metabolites in urine by GC-MS developed using rat liver microsomes

      THERAPEUTIC DRUG MONITORING
    90. Simpson, MM; Goetz, RR; Devlin, MJ; Goetz, SA; Walsh, BT
      Weight gain and antipsychotic medication: Differences between antipsychotic-free and treatment periods

      JOURNAL OF CLINICAL PSYCHIATRY
    91. Sajatovic, M; Brescan, DW; Perez, DE; DiGiovanni, SK; Hattab, H; Ray, JB; Bingham, CR
      Quetiapine alone and added to a mood stabilizer for serious mood disorders

      JOURNAL OF CLINICAL PSYCHIATRY
    92. Chen, NC; Bedair, HS; McKay, B; Bowers, MB; Mazure, C
      Clozapine in the treatment of aggression in an adolescent with autistic disorder

      JOURNAL OF CLINICAL PSYCHIATRY
    93. Compton, MT; Miller, AH
      Priapism associated with conventional and atypical antipsychotic medications: A review

      JOURNAL OF CLINICAL PSYCHIATRY
    94. Williams, R
      Optimal dosing with risperidone: Updated recommendations

      JOURNAL OF CLINICAL PSYCHIATRY
    95. Seger, A; Lamberti, JS
      Priapism associated with polypharmacy

      JOURNAL OF CLINICAL PSYCHIATRY
    96. Lewis, M; McCrone, P; Frangou, S
      Service use and costs of treating schizophrenia with atypical antipsychotics

      JOURNAL OF CLINICAL PSYCHIATRY
    97. Tamminga, CA
      Introduction - Evaluating clinical trial data from schizophrenia research

      JOURNAL OF CLINICAL PSYCHIATRY
    98. Lieberman, JA
      Hypothesis and hypothesis testing in the clinical trial

      JOURNAL OF CLINICAL PSYCHIATRY
    99. Keith, SJ
      Evaluating characteristics of patient selection and dropout rates

      JOURNAL OF CLINICAL PSYCHIATRY
    100. Casey, DE
      Clinical trial design issues in schizophrenic research

      JOURNAL OF CLINICAL PSYCHIATRY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/12/19 alle ore 15:25:01